Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Daiichi Sankyo Company Limited
sales of 986.45 billion Japanese Yen [US$8.61 billion]
of which 94%
was prescription drugs),
Astellas Pharma Incorporated
(1.37 trillion Japanese Yen [US$11.98 billion]
of which 57%
was Other), and
Eisai Company Limited
(547.92 billion Japanese Yen [US$4.78 billion]
of which 49%
was Pharmaceutical Business -Japan).
Takeda Pharmaceutical Company Limited reported sales of ¥1.81 trillion (US$15.78 billion)
March of 2016.
a very small
increase of 1.7%
versus 2015, when the company's sales were ¥1.78 trillion.
Sales at Takeda Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 27%).
Sales of Healthcare saw an increase
that was more than double the company's growth rate: sales were up
8.9% in 2016, from
¥73.58 billion to ¥80.09 billion.
Not all segments of Takeda Pharmaceutical Company Limited experienced an increase in sales in 2016:
sales of Other fell 12.4% to ¥78.61 billion.